Navigation Links
NOTES research activities increase with grants from Olympus medical Systems totaling $1 million

OAK BROOK, Ill., July 10, 2008 The Natural Orifice Surgery Consortium for Assessment and Research™ (NOSCAR™), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), today announced Olympus' continuing commitment to funding research in an emerging transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery™ (NOTES™), with a $500,000 grant to the existing Olympus Research Fund supporting NOTES™ research. The grant increases Olympus' total funding to $1 million. NOTES™, which is performed by using the patient's natural openings for surgery, will be discussed among researchers from July 10-12, 2008 at the 3rd International Conference on NOTES™ in San Francisco, Calif.

"The Olympus Research Fund established in 2007 has already supported nine studies producing results that are advancing the understanding and applications of this fascinating and innovative technique," said Haruhito Morishima, president, Olympus Medical Systems Corporation. "As the world's leader in endoscopy, we are proud to continue our support of NOTES™ research, an approach that could ultimately represent a major paradigm shift in minimally invasive therapy."

This fund was established with an initial $500,000 grant from Olympus. Though studies from this grant are ongoing, one of the nine studies that has been completed is expected to be published in two peer-reviewed journals. Researchers will learn more about these studies at the upcoming NOTES™ conference.

"NOTES™ is moving forward more rapidly than initially expected," said Robert H. Hawes, MD, FASGE, ASGE past president and NOSCAR™ Joint Committee co-chair. "Three years ago, we never anticipated the progress in the research arena that has been made in such a short period. Thanks to leaders such as Olympus, we are making great strides in NOTES™ technology."

NOSCAR™ received more than 40 requests for funding from this new Olympus grant. NOSCAR™ will determine the grant recipients in mid-July. A listing of those who received funding will be posted to

"We are most grateful to Olympus for its ongoing commitment and vision in supporting NOTES™ research," said David W. Rattner, MD, SAGES past president and NOSCAR™ Joint Committee co-chair.


Contact: Anne Brownsey
American Society for Gastrointestinal Endoscopy

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
3. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
4. Flextronics Announces Redemption and Change of Control Repurchase Offer for Solectron 8.00% Senior Subordinated Notes and Planned Change of Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
5. Flextronics Announces Change in Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
6. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
7. Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes
8. MediNotes EMR Now Interfaces With 76 Practice Management Systems, Allowing More Medical Practices to Replace Their Patients Aging Paper Medical Records
9. AllerNotes Help Take Food Allergies Off the Table
10. MQ Associates, Inc. Announces Expiration of its Tender Offers for its 12 1/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Medquest, Inc.s 11 7/8% Senior Subordinated Notes Due 2012 (CUSIP No. 58505DAD1)
11. MQ Associates, Inc. Announces Cash Tender Offer for 121/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Related Consent Solicitation
Post Your Comments:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease Control ... of October . PhysicianOne Urgent Care is helping communities across ... NY , by offering no-cost* flu shots through the end of ... by certain health insurance regulations. ... best time to get a flu shot is by the end of ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:10/2/2017)... Denmark , Oct. 2, 2017 The Rebound ... in the struggle to reverse the tide of prescription drug ... for regulating their medicine intake and stepping down their dosage ... set to launch in December 2017; the first 100,000 people ... Learn more at ...
Breaking Medicine Technology: